From: Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome
 | All IBD | CD | UC | ||||||
---|---|---|---|---|---|---|---|---|---|
 | Incidence* | cRR (95% CI) | aRR (95% CI) | Incidence* | cRR (95% CI) | aRR (95% CI) | Incidence* | cRR (95% CI) | aRR (95% CI) |
Female | 81.5 | 1.0 | 1.0 | 23.3 | 1.0 | 1.0 | 46.6 | 1.0 | 1.0 |
Male | 98.5 | 1.21 (0.74, 1.96) | 2.21 (1.35, 3.62) | 43.2 | 1.85 (0.78, 4.44) | 3.55 (1.47, 8.54) | 43.2 | 0.93 (0.48, 1.80) | 1.66 (0.84, 3.28) |
≤1 IGE | 89.4 | 1.0 | 1.0 | 40.1 | 1.0 | 1.0 | 37.0 | 1.0 | 1.0 |
>1 IGE | 274.7 | 3.07 (1.42, 6.64) | 2.19 (1.01, 4.75) | 196.2 | 4.90 (1.93, 12.42) | 1.51 (0.36, 6.32) | 78.5 | 2.12 (0.51, 8.81) | 3.49 (1.36, 8.95) |
Not deployed | 104.3 | 1.0 | 1.0 | 40.5 | 1.0 | 1.0 | 49.8 | 1.0 | 1.0 |
Deployed | 29.6 | 0.28 (0.10, 0.77) | 0.33 (0.12, 0.91) | 22.2 | 0.55 (0.17, 1.78) | 0.65 (0.20, 2.13) | 7.4 | 0.15 (0.02, 1.08) | 0.17 (0.02, 1.27) |
No IBS | 27.8 | 1.0 | 1.0 | 7.3 | 1.0 | 1.0 | 16.1 | 1.0 | 1.0 |
IBS | 238.1 | 8.56 (5.18, 14.17) | 9.40 (5.64, 15.6) | 104.7 | 14.32 (5.59, 36.67) | 17.30 (6.71, 44.62) | 104.7 | 6.51 (3.29, 12.88) | 6.53 (3.25, 13.11) |